Qatar, along with other Middle East countries, has a heavy burden of genetic disorders, which is mostly duo to high consanguinity rates. Multiple genetically predisposed disorders are relatively common among Qataris including inherited rare disorders as well as some complex diseases.

The investigation of Qatari-specific genetic variants is essential to understand disease pathogenesis and identify more efficient therapeutic approaches. For this purpose, QGP is collaborating with the various national clinical and research stakeholders (e.g. HBKU, QBRI, Sidra, Cornell, HMC pathology, Heart Hospital, Cancer Centre and others) to produce data that would help develop new more effective clinical practices.